Frier Levitt attorney Martha Rumore published an article, “Regulatory Considerations Regarding the 503B to 503A Compounding Model For Community Pharmacies” in Pharmacy Times. On June 27, 2023, the FDA issued draft guidance allowing 503A... Read More
Articles | Life Sciences | News | Pharmacy Law